Exelixis reported $101.56M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 96.68M 9.23M
Agios Pharmaceuticals AGIO:US $ 31.51M 13K
Akebia Therapeutics AKBA:US $ 44.33M 498K
Amgen AMGN:US $ 1.23B 197M
AstraZeneca AZN:LN 3.06B 1.03B
Biomarin Pharmaceutical BMRN:US $ 194.62M 22.94M
Eisai 4523:JP 110.49B 9.03B
Takeda 4502:JP 223.43B 7.65B